Indeed, NPBWR1 shares 96 % percent of its protein partners with both GNAI1 and GNAI2 (26 out of 27 protein interactions), revealing that they might act on similar molecular pathways within prostate cancer. Here, NPBWR1 is linked to prostate carcinoma.